Frontlight ResearchEarly access
Colorectal cancer trials in Italy
157 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Active, not recruitingA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Aviano, Milan, Rome
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 3Taking peoplePHASE III RANDOMIZED STUDY OF FOLFOXIRI PLUS BEVACIZUMAB AND ATEZOLIZUMAB VERSUS FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF UNRESECTABLE pMMR AND IMMUNOSCORE IC-HIGH METASTATIC COLORECTAL CANCER PATIENTS. The AtezoTRIBE2 Study
- Where
- Arezzo, Aviano, Bari, Brescia, Catania, Cuneo, Florence, Grosseto, Leghorn, Lucca, Meldola, Milan, Modena, Monserrato, Naples, Novara, Padova, Parma, Piacenza, Pisa, Prato, Ravenna, Reggio Emilia, Rome, San Giovanni Rotondo, Tricase, Udine, Varese, Vicenza, Viterbo
- Age
- 18 years and over
- People
- 238
- Run by
- Fondazione GONO G.I.
See details and how to join2023-506632-32-00 - Phase 1/2Taking peopleBeamion BCGC-1: A study to find a suitable dose of zongertinib used alone and in combination with other treatments to test whether it helps people with different types of HER2+ cancer that has spread
- Where
- Ancona, Candiolo, Meldola, Milan, Misterbianco, Naples, Rozzano
- Age
- 18 years and over
- People
- 181 worldwide
- Run by
- Boehringer Ingelheim International GmbH
See details and how to join2023-509566-38-00 - Phase 2Taking peopleA Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
- Where
- Milan, Roma, Udine
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06567782 - No phaseNot yet taking people in ItalyNutritional Supplementation to Improve Colorectal Cancer Surgery
- Where
- Rozzano
- Age
- 18 years and over
- People
- 190
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT07599501 - Phase 1Taking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Milan, Reggio Emilia
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - No phaseEnrolling by invitationCOLORECTAL CANCER: SINGLE CENTER EXPERIENCE
- Where
- Roma
- People
- 37
- Run by
- University of Roma La Sapienza
See details and how to joinNCT07576049 - No phaseTaking peopleRecurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection vs. Endoscopic Submucosal Dissection
- Where
- Bologna, Genova, Milan, Modena, Reggio Emilia
- Age
- 18 years and over
- People
- 282
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT06815406 - Phase 1Not yet taking people in ItalyA Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
- Where
- Rome
- Age
- 18 years to 75 years
- People
- 96
- Run by
- Philogen S.p.A.
See details and how to joinNCT07566897 · EU 2025-522243-17-00 - No phaseEnrolling by invitationSafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
- Where
- Rozzano
- Age
- 22 years and over
- People
- 108 worldwide
- Run by
- SafeHeal Inc
See details and how to joinNCT07116668 - No phaseNot yet taking people in ItalyOutcomes After Liver and Biliary Resection at a High-Volume Center
- Where
- Pistoia
- Age
- 18 years and over
- People
- 1,000
- Run by
- Azienda USL Toscana Centro
See details and how to joinNCT07556835 - Phase 2Taking peopleSequential immunochemotherapy treatment with Pembrolizumab plus Dendritic Cell (DC) Vaccine followed by Trifluridine/Tipiracil plus Bevacizumab in refractory mismatch-repair-proficient (pMMR) or microsatellite-stable (MSS) metastatic colorectal cancer
- Where
- Meldola, Tricase
- Age
- 18 years and over
- People
- 36
- Run by
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
See details and how to join2024-514053-30-00 - No phaseTaking peopleExogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Where
- Milan
- Age
- 18 years to 49 years
- People
- 2,300 worldwide
- Run by
- San Raffaele University
See details and how to joinNCT05732623 - No phaseTaking peopleLynch Syndrome X-Talk of Enteral Mucosa With Immune System
- Where
- Cagliari, Milan, Palermo
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- San Raffaele University
See details and how to joinNCT06708429 - No phaseTaking peopleVideocapsule Endoscopy in Lynch Syndrome
- Where
- Milan
- Age
- 18 years and over
- People
- 100
- Run by
- San Raffaele University
See details and how to joinNCT05704010 - No phaseTaking peopleNon-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy
- Where
- Milan
- Age
- 12 years and over
- People
- 26
- Run by
- Niguarda Hospital
See details and how to joinNCT07235865 - No phaseTaking peopleAdvanced Therapies for Liver Metastases
- Where
- Milan
- Age
- 18 years and over
- People
- 625
- Run by
- IRCCS San Raffaele
See details and how to joinNCT04622423 - No phaseTaking peopleMIMICC Study in Patients With Colorectal Cancer
- Where
- Candiolo
- Age
- 18 years to 75 years
- People
- 2,500
- Run by
- Fondazione del Piemonte per l'Oncologia
See details and how to joinNCT07494201 - No phaseTaking peopleA Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
- Where
- Candiolo
- Age
- 18 years and over
- People
- 850
- Run by
- Fondazione del Piemonte per l'Oncologia
See details and how to joinNCT07469709 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Brescia, Negrar
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleA Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity
- Where
- Candiolo
- Age
- 18 years and over
- People
- 200
- Run by
- Fondazione del Piemonte per l'Oncologia
See details and how to joinNCT06952101 - No phaseTaking peopleLiquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
- Where
- Milan
- Age
- 18 years and over
- People
- 1,200
- Run by
- San Raffaele University
See details and how to joinNCT07450612 - Phase 2Taking peopleUpfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
- Where
- Bari, Florence, Milan, Naples, Padova, Pisa, Ravenna, Rome, Rozzano, Tricase, Udine, AOU Policlinico di Modena
- Age
- 18 years and over
- People
- 42 worldwide
- Run by
- Gruppo Oncologico del Nord-Ovest
See details and how to joinNCT07407465 · EU 2024-519479-24-00 - Phase 3Taking peopleContinuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
- Where
- Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro, Florence, Lecce, Meldola, Milan, Mirabella Eclano, Naples, Padova, Palermo, Pisa, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo, Sassari, Statte, Tricase, Veneto
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- University of Campania Luigi Vanvitelli
See details and how to joinNCT07389265 - Phase 3Active, not recruitingStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Genoa, Milan, Monserrato, Naples, Padova, Pisa, Reggio Emilia, Rome, Rozzano
- Age
- 18 years and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00